Anti-neutrophil cytoplasmic antibody-associated systemic vasculitis: nature or nurture?

被引:6
|
作者
Gatenby, P. A. [1 ,2 ]
机构
[1] Australian Natl Univ, Canberra Hosp, Dept Immunol, Canberra, ACT, Australia
[2] Australian Natl Univ, Sch Med, Canberra, ACT, Australia
关键词
vasculitis; anti-neutrophil cytoplasmic antibody; vitamin D; silica; genetics; CHURG-STRAUSS-SYNDROME; ANCA-ASSOCIATED VASCULITIS; PRIMARY RENAL VASCULITIS; WEGENERS-GRANULOMATOSIS; MICROSCOPIC POLYANGIITIS; POLYARTERITIS-NODOSA; STAPHYLOCOCCUS-AUREUS; INCREASING INCIDENCE; SEASONAL-VARIATIONS; RISK-FACTOR;
D O I
10.1111/j.1445-5994.2011.02705.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review examines the environmental and genetic contributions to the anti-neutrophil cytoplasmic antibody-associated systemic vasculitides. The dominant environmental risk factors appear to be silica exposure for all three syndromes, and vitamin D deficiency is strongly suggested by the latitude and ultraviolet radiation gradient observed for Wegener's granulomatosis and ChurgStrauss syndrome. Genetic factors are generally not very strong, consistent with the rarity of these conditions in children. However, multiple genetic factors, each with a relatively small effect, may combine to create a state of susceptibility towards autoimmunity. With infection as a triggering agent, it is possible to synthesise a pathogenetic hypothesis that accounts for both environmental and genetic effects in regard to both necrotising vasculitis and granuloma formation.
引用
收藏
页码:351 / 359
页数:9
相关论文
共 50 条
  • [1] Anti-neutrophil cytoplasmic antibody-associated systemic vasculitis: nature or nurture?
    Gatenby, P. A.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (09) : 1066 - 1067
  • [2] Our experience with anti-neutrophil cytoplasmic antibody-associated systemic vasculitis
    Gujadhur, A.
    McMahon, L.
    Holt, S.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (09) : 1066 - 1066
  • [3] Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Sun, Xiao-Jing
    Li, Zhi-Ying
    Chen, Min
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2023, 4 (01): : 11 - 21
  • [4] A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Moura, Marta Casal
    Branco, Carolina
    Martins-Martinho, Joana
    Ferraro, Jose Luis
    Berti, Alvise
    Nogueira, Estela
    Ponte, Cristina
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [5] Influenza vaccination and anti-neutrophil cytoplasmic antibody-associated vasculitis
    Wiwanitkit, Viroj
    NEPHROLOGY, 2015, 20 (07) : 511 - 512
  • [6] Novel Therapies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Richard W. Lee
    David P. D’Cruz
    Drugs, 2008, 68 : 747 - 770
  • [7] Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis
    Hruskova, Zdenka
    Geetha, Duvuru
    Tesar, Vladimir
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i159 - i163
  • [8] Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis
    Tervaert, JWC
    Stegeman, CA
    Kallenberg, CGM
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (02): : 211 - 217
  • [9] AN OVERVIEW OF PHARMACOTHERAPY FOR ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
    Stasi, R.
    DRUGS OF TODAY, 2010, 46 (12) : 919 - 928
  • [10] Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
    Binda, Valentina
    Favi, Evaldo
    Calatroni, Marta
    Moroni, Gabriella
    MEDICINA-LITHUANIA, 2021, 57 (12):